One stop for all your health tips

EVERYDAY CARRY: Forme | FashionBeans
EVERYDAY CARRY: Forme | FashionBeans
Dress Code: Bottega | FashionBeans
Dress Code: Bottega | FashionBeans
8 of the coolest graphic tees for men from RAPANUI
8 of the coolest graphic tees for men from RAPANUI
MENS HEALTH FITS. ALL RIGHTS RESERVED.

7

Aug , 2024
Yogurt with probiotics and honey boosts gut bacteria but no digestive or cognitive benefits
Tag: in vivo

Yogurt with probiotics and honey boosts gut bacteria but no digestive or cognitive benefits

In a recent study published in The Journal of Nutrition, a team of researchers at the University of Illinois Urbana-Champaign conducted a randomized, crossover trial to investigate whether the consumption of yogurt containing the probiotic bacteria Bifidobacterium animalis subspecies lactis along with honey had an impact on the probiotic enrichment, intestinal transit time, digestive health, […]

1

Aug , 2024
Continuous noninvasive blood pressure monitoring using resonance sonomanometry
Tag: in vivo

Continuous noninvasive blood pressure monitoring using resonance sonomanometry

In a recent study published in the PNAS Nexus, researchers introduced and validated resonance sonomanometry (RSM) for noninvasive, calibration-free continuous blood pressure (BP) measurement using ultrasound imaging. Study: Resonance sonomanometry for noninvasive, continuous monitoring of blood pressure. Image Credit: Vita_Dor/Shutterstock.com Background  BP is essential for assessing patient health, with continuous, noninvasive measurement being highly desirable. While invasive […]

21

Jul , 2024
Research may pave the way for systemic targeted therapy for patients with pseudomyxoma peritonei
Tag: in vivo

Research may pave the way for systemic targeted therapy for patients with pseudomyxoma peritonei

Published in Clinical Cancer Research, results of a preclinical study led by investigators of the Vall d’Hebron Institute of Oncology’s (VHIO) Stem Cells and Cancer Group, headed by Héctor G. Palmer, pave the way for systemic targeted therapy in patients with pseudomyxoma peritonei, a rare form of cancer with very few therapeutic options available. This […]

15

Jul , 2024
New brain targets for GLP1-based obesity drugs may reduce weight without nausea
Tag: in vivo

New brain targets for GLP1-based obesity drugs may reduce weight without nausea

In a recent study published in the journal Nature, a group of researchers identified brain circuits that can be targeted by glucagon-like peptide-1 (GLP1)-based obesity drugs to promote weight loss without causing adverse side effects. Study: Dissociable hindbrain GLP1R circuits for satiety and aversion. Image Credit: MillaF / Shutterstock Background  A long-standing question concerns the relationship between […]

7

Jul , 2024
Breakthrough humanized mouse model offers new insights for immunotherapy development
Tag: in vivo

Breakthrough humanized mouse model offers new insights for immunotherapy development

A breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling. Scientists at The University of Texas Health Science Center at San Antonio have created a humanized mouse model with a human immune system and a human-like gut microbiome that is capable of mounting specific antibody responses. The scientists were led by Paolo […]

9

May , 2024
Novel bispecific antibodies show promise against evolving SARS-CoV-2 variants
Tag: in vivo

Novel bispecific antibodies show promise against evolving SARS-CoV-2 variants

In a recent research paper uploaded to the bioRxiv preprint* server, researchers developed and tested novel bispecific antibodies (bsAbs) comprising both the N-terminal domain (NTD) and the receptor binding domain (RBD) for their efficacy against emergent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs). These antibodies were synthesized using monoclonal antibodies (mAbs) […]

8

May , 2024
Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness
Tag: in vivo

Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness

Retinal degeneration can be inherited or acquired. In the former case, it is an incurable and progressive condition. A recent study published in The New England Journal of Medicine investigated the potential use of gene editing to correct a congenital retinal degeneration called CEP290 that causes early-onset vision loss. Study: Gene Editing for CEP290-Associated Retinal Degeneration. Image […]

8

May , 2024
APOE4 gene linked to early onset Alzheimer’s, target for therapeutic intervention
Tag: in vivo

APOE4 gene linked to early onset Alzheimer’s, target for therapeutic intervention

In a recent study published in the journal Nature Medicine, researchers investigated the effect of APOE4 (short for Apolipoprotein E4) homozygosity on Alzheimer’s disease (AD) using pathological, clinical, and biomarker analyses. They found that APOE4 homozygotes showed AD pathology and elevated AD biomarker levels from 55 years of age, representing a distinct variant of AD […]

5

Mar , 2024
New method simplifies production of limb progenitor cells from fibroblasts
Tag: in vivo

New method simplifies production of limb progenitor cells from fibroblasts

In a collaborative study, researchers from Kyushu University and Harvard Medical School have identified proteins that can turn or “reprogram” fibroblasts -; the most commonly found cells in skin and connective tissue -; into cells with similar properties to limb progenitor cells. Publishing in Developmental Cell, the researchers’ findings have enhanced our understanding of limb development and have set […]

16

Jan , 2024
Nanobots for bladder cancer treatment, promising high efficacy and targeted delivery
Tag: in vivo

Nanobots for bladder cancer treatment, promising high efficacy and targeted delivery

Bladder cancer is currently treated in its earlier stages by localized intravesical chemotherapy or immunotherapy after removing the tumor. However, recurrences occur in up to 70% of patients at 5 years, while up to 30% fail to respond. This means a constant need to monitor and retreat these patients, driving costs sky-high for the treatment […]
1 2